“I think we are entering this phase here where we will start to outperform marketing capture share.”

In context

“u. Operator: Thank you. Our next question will come from Matt Taylor from Jefferies. Your line is open. Matt Taylor: Hi. Good morning. Thanks for taking the question. I thought it would be worth spending a minute on EP given you have this nice series of launches here. You seem to be gaining traction with Volt already. Could you comment on market dynamics and your aspirations in the market, maybe just talk about how you think the AF market will continue to grow and you are committing to growing above market in the second half. Could you talk about how that could continue into next year and the kind of share aspirations that you have? Robert Ford: Sure. I am not gonna give specific targets on share. I think where I will leave it right now is, we do expect to grow faster than the market. And I think we are entering this phase here where we will start to outperform marketing capture share. I think we saw early signs of that in '2, Matt. Sales increased every month in the quarter, very good progress there. But I think what we will really start to see that happen in the second half, as we transition from a limited market release to full market release of Bolt in the US and then continue to roll out Tactiflex Duo internationally. We continue to get very good feedback from physicians and doctors around the world that are using the product. I would say Bolt. For Melissa, what I hear a lot about Bolt is just the continued integration to the Mapping System And Not Having To Use a mapping system or a mapping infrastructure that is a little bit subpar Versus Where The Market Leading Mapping Systems Are. So Now You Do not Really Have To take that step back a little bit. You have got”